A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Acute Pain Trial) (ADOPT PGx)
A Depression and Opioid Pragmatic Trial in Pharmacogenetics
Sponsor: Duke University
Listed as NCT05966129, this NA trial focuses on Acute Pain and remains completed. Sponsored by Duke University, it has been updated 11 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Jul 2025 — Present [monthly]
Completed NA
-
Feb 2025 — Jul 2025 [monthly]
Completed NA
-
Nov 2024 — Feb 2025 [monthly]
Completed NA
-
Sep 2024 — Nov 2024 [monthly]
Completed NA
-
Aug 2024 — Sep 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 6 earlier versions
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Dec 2023 — Jun 2024 [monthly]
Active Not Recruiting NA
-
Nov 2023 — Dec 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2023 — Nov 2023 [monthly]
Recruiting NA
-
Aug 2023 — Sep 2023 [monthly]
Recruiting NA
First recorded
Mar 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Duke University
- Icahn School of Medicine at Mount Sinai
- Indiana University School of Medicine
- National Human Genome Research Institute (NHGRI)
- University of Florida
- Vanderbilt University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .